Effects of Digeda-4 Decoction on the CYP450 Activities in Rats Using a Cocktail Method by HPLC

Overview

Journal Biomed Res Int

Publisher Wiley

Specialties Biomedical Engineering
Biotechnology
General Medicine

Date 2018 Nov 15

PMID 30426002

Citations 5

Authors

Dong Zhang

Guo-Dong Wu

Yan-Dong Zhang

Jian-Ping Xu

Hai-Tao Zhen

Min-Hui Li

Affiliations

Soon will be listed here.

Abstract

Digeda-4 decoction is a traditional Mongolian medicine; its effects on cytochrome (CYP) enzymes are still unclear. CYP450 isoenzymes are the main drug metabolic enzymes, and their activities may be induced or inhibited by certain drugs, which lead to drug interactions in clinical use. Effects of Digeda-4 decoction on the activities of CYP450 subtype enzymes CYP1A2, CYP2C9, CYP2E1, CYP2C19, and CYP3A4 in rats were studied by cocktail method, and the pharmacokinetic parameters of five specific probe drugs (theophylline, tolbutamide, chlorzoxazone, omeprazole, and midazolam) were calculated by DAS software; changes of parameters can be used to evaluate the effects of Digeda-4 decoction on enzyme activities. The experimental rats were divided into three groups: control group, Digeda group, and positive group. Rats in Digeda group were given Digeda-4 decoction through continuous gavage for 14 days. After fasting for 12 hours, the mixed probes drug solution was injected into the tail vein; the blood samples were collected through the orbital vein at different time points. The concentrations of probe drugs in rat plasma were measured by HPLC. Compared with the control group, the half-life time (t) of the pharmacokinetic parameters of theophylline, tolbutamide, omeprazole, and midazolam was prolonged, the area under the curve (AUC) increased, and the plasma clearance (CL) decreased in the Digeda group. Continuous gavage administration for 14 days may inhibit the activities of CYP450 subtype enzymes CYP1A2, CYP2C9, CYP2C19, and CYP3A4 of rats. Herb-drug interaction should be noted between Digeda-4 decoction and the drugs metabolized by CYP1A2, CYP2C9, CYP2C19, and CYP3A4.

Citing Articles

Probe substrates assay estimates the effect of polyphyllin H on the activity of cytochrome P450 enzymes in human liver microsomes.

Wang E, Wang M, Gao M Pharmacol Res Perspect. 2024; 12(5):e70002.

PMID: 39210686 PMC: 11362609. DOI: 10.1002/prp2.70002.

Inhibition and Induction by Poziotinib of Different Rat Cytochrome P450 Enzymes and in an Cocktail Method.

Wang J, Chen F, Jiang H, Xu J, Meng D, Geng P Front Pharmacol. 2021; 11:593518.

PMID: 33746741 PMC: 7970697. DOI: 10.3389/fphar.2020.593518.

Effects of mongolian medicine Retz. on 6 CYP450 enzymes in rats.

Wu G, Dong Z, Dong J, Wei L, Shi R, Kang S Int J Clin Exp Pathol. 2021; 13(12):3128-3138.

PMID: 33425113 PMC: 7791385.

Calycosin Influences the Metabolism of Five Probe Drugs in Rats.

Wu M, Lin Y, Wei Y, Du H, Ying X, Tan W Drug Des Devel Ther. 2020; 14:429-434.

PMID: 32099327 PMC: 6996205. DOI: 10.2147/DDDT.S236221.

Effect of Naoxintong Capsules on the Activities of CYP450 and Metabolism of Metoprolol Tartrate in Rats Evaluated by Probe Cocktail and Pharmacokinetic Methods.

Ouyang H, Shen J, Huang X, Ma W, Jia Q, Yao G Evid Based Complement Alternat Med. 2019; 2019:5242605.

PMID: 31662775 PMC: 6778862. DOI: 10.1155/2019/5242605.

References

Liu X, You C, Yang Y, Zhang L, Qian Z . [Anatomy and adaptation to environment study of endangered alpine medical plant Neopicrorhiza scrophulariiflora]. Zhong Yao Cai. 2010; 33(4):507-10. View

Ingelman-Sundberg M . Pharmacogenetics of cytochrome P450 and its applications in drug therapy: the past, present and future. Trends Pharmacol Sci. 2004; 25(4):193-200. DOI: 10.1016/j.tips.2004.02.007. View

Jin S, Ha H, Seo C, Shin H, Jeong S . Expression of Hepatic Cytochrome P450s in Rats Administered with , a Traditional Herbal Formula. Pharmacogn Mag. 2018; 13(Suppl 4):S822-S827. PMC: 5822506. DOI: 10.4103/pm.pm_107_17. View

Nebert D, Dalton T . The role of cytochrome P450 enzymes in endogenous signalling pathways and environmental carcinogenesis. Nat Rev Cancer. 2006; 6(12):947-60. DOI: 10.1038/nrc2015. View

Brosen K . Some aspects of genetic polymorphism in the biotransformation of antidepressants. Therapie. 2004; 59(1):5-12. DOI: 10.2515/therapie:2004003. View

Brandolese R, Scordo M, Spina E, Gusella M, Padrini R . Severe phenytoin intoxication in a subject homozygous for CYP2C9*3. Clin Pharmacol Ther. 2001; 70(4):391-4. View

Dansette P, Rosi J, Bertho G, Mansuy D . Cytochromes P450 catalyze both steps of the major pathway of clopidogrel bioactivation, whereas paraoxonase catalyzes the formation of a minor thiol metabolite isomer. Chem Res Toxicol. 2011; 25(2):348-56. DOI: 10.1021/tx2004085. View

Zhou S, Chan E, Pan S, Huang M, Lee E . Pharmacokinetic interactions of drugs with St John's wort. J Psychopharmacol. 2004; 18(2):262-76. DOI: 10.1177/0269881104042632. View

Brewer C, Chen T . Hepatotoxicity of Herbal Supplements Mediated by Modulation of Cytochrome P450. Int J Mol Sci. 2017; 18(11). PMC: 5713322. DOI: 10.3390/ijms18112353. View

10.

Lin Y, Wei Y, Hu X, Wu M, Ying X, Ding M . Influences of on the CYP450 Activities in Rats Using a Cocktail Method by UHPLC-MS/MS. Biochem Res Int. 2018; 2018:1467143. PMC: 5903335. DOI: 10.1155/2018/1467143. View

11.

Kidd R, Straughn A, Meyer M, Blaisdell J, Goldstein J, Dalton J . Pharmacokinetics of chlorpheniramine, phenytoin, glipizide and nifedipine in an individual homozygous for the CYP2C9*3 allele. Pharmacogenetics. 1999; 9(1):71-80. DOI: 10.1097/00008571-199902000-00010. View

12.

Wang B, Yang S, Hu J, Li Y . Multifaceted interaction of the traditional Chinese medicinal herb Schisandra chinensis with cytochrome P450-mediated drug metabolism in rats. J Ethnopharmacol. 2014; 155(3):1473-82. DOI: 10.1016/j.jep.2014.07.026. View

13.

Zahiruddin S, Khan W, Nehra R, Alam M, Mallick M, Parveen R . Pharmacokinetics and comparative metabolic profiling of iridoid enriched fraction of Picrorhiza kurroa - An Ayurvedic Herb. J Ethnopharmacol. 2016; 197:157-164. DOI: 10.1016/j.jep.2016.07.072. View

14.

Zanger U, Schwab M . Cytochrome P450 enzymes in drug metabolism: regulation of gene expression, enzyme activities, and impact of genetic variation. Pharmacol Ther. 2013; 138(1):103-41. DOI: 10.1016/j.pharmthera.2012.12.007. View

15.

Yun B, Yang H, Weon J, Lee J, Eom M, Ma C . Simultaneous Determination of Eight Bioactive Compounds in Dianthus superbus by High-performance Liquid Chromatography. Pharmacogn Mag. 2016; 12(Suppl 2):S264-9. PMC: 4883090. DOI: 10.4103/0973-1296.182159. View

16.

Xiao W, Li S, Wang S, Ho C . Chemistry and bioactivity of Gardenia jasminoides. J Food Drug Anal. 2017; 25(1):43-61. PMC: 9333430. DOI: 10.1016/j.jfda.2016.11.005. View

17.

Sychev D, Ashraf G, Svistunov A, Maksimov M, Tarasov V, Chubarev V . The cytochrome P450 isoenzyme and some new opportunities for the prediction of negative drug interaction in vivo. Drug Des Devel Ther. 2018; 12:1147-1156. PMC: 5951216. DOI: 10.2147/DDDT.S149069. View

18.

Mai I, Kruger H, Budde K, Johne A, Brockmoller J, Neumayer H . Hazardous pharmacokinetic interaction of Saint John's wort (Hypericum perforatum) with the immunosuppressant cyclosporin. Int J Clin Pharmacol Ther. 2000; 38(10):500-2. DOI: 10.5414/cpp38500. View

19.

Luo J, Chen X, Kong L . Three new triterpenoid saponins from Dianthus superbus. Chem Pharm Bull (Tokyo). 2011; 59(4):518-21. DOI: 10.1248/cpb.59.518. View

20.

Bajad S, Bedi K, Singla A, Johri R . Antidiarrhoeal activity of piperine in mice. Planta Med. 2001; 67(3):284-7. DOI: 10.1055/s-2001-11999. View